Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: Transcranial direct current stimulation (tDCS) holds promise as a therapeutic intervention for major depressive disorder (MDD). A more precise understanding of its underlying mechanisms may aid in the identification of subsets of patients responsive to tDCS within the context of precision psychiatry. Objective: In this ancillary investigation of the Escitalopram vs. Electrical Current Therapy for Treating Depression Clinical Study (ELECT‐TDCS), we investigated whether plasma levels of several cytokines and neurotrophic factors associated with major depression or antidepressant response predicted tDCS effects. Methods: We examined, in 236 patients at 3 timepoints during a 10‐week treatment course, plasma levels of nerve growth factor (NGF), brain‐derived (BDNF), glial‐cell line derived neurotrophic factor (GDNF), the interleukins (IL) IL‐1ß, IL‐6, IL‐8, IL‐10, IL‐12p70, IL‐18, IL‐33, tumor necrosis factor‐alpha (TNF‐alpha), and its soluble receptors sTNFr1 and sTNFr2. General linear models and mixed‐models analyses of variance were used to respectively assess whether plasma levels of these molecules (1) predicted tDCS antidepressant improvement and (2) changed over time. Results: After correction for multiple comparisons (false discovery rate method), NGF baseline levels predicted early depression improvement for tDCS vs. escitalopram, whilst other biomarkers did not significantly predict treatment improvement. The levels of IL12p70, IL10, IL‐1ß, IL‐8 and sTNFr1 decreased over time, regardless of allocation group and clinical response. Conclusion: In general, peripheral biomarkers were not associated with the outcome. The post‐hoc finding of baseline NGF levels predicting early depression improvement for tDCS should be explored in further studies. HighlightsBlood inflammation and neurotrophic factors biomarkers of ELECT‐TDCS were examined.Data were collected in 236 patients at 3 timepoints.Biomarkers decreased over time, regardless of intervention group or clinical response.BDNF was not associated with treatment response or predicted tDCS effects.Among the 13 molecules analyzed, NGF predicted early antidepressant tDCS response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“Although distinct, these theories are complementary since heightened stress response, observed in MDD, leads to increased activity of the hypothalamic-pituitary-adrenal axis and higher cortisol levels (Gold, 2015; Pariante, 2017) which could lead to an upregulation of pro-inflammatory cytokines accompanied by a downre…”
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Brunoni, A. R., Nitsche, M. A., Bolognini, N., Bikson, M., Wagner, T., Merabet, L., Edwards, D. J., Valero-Cabre, A., Rotenberg, A., Pascual-Leone, A., et al. (2012) · Brain stimulation · doi:10.1016/j.brs.2011.03.002 · Cited by 1,445 · cited 1×
“Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation intervention in which a weak electric current is applied over the scalp that induces changes in cortical excitability (Brunoni et al., 2012).”
Self-citationPeripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · cited 2×
“, 2006) – this theory is supported by findings that acute increases in pro-inflammatory cytokines may lead to depressive episodes (Dellagioia and Hannestad, 2010), that higher levels of cytokines and chemokines are observed in depressed compared to healthy subjects (Kohler et al., 2017), which decrease after treatment…”
Self-citationKirkham, J. J., Dwan, K. M., Altman, D. G., Gamble, C., Dodd, S., Smyth, R., & Williamson, P. R. (2010) · BMJ · doi:10.1136/bmj.c365 · Cited by 1,133 · cited 1×
“In fact, the prevalence of outcome reporting bias is an important issue in many research fields, leading to an overestimated effect size of the outcome under investigation (Kirkham et al., 2010).”
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Self-citationKöhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702 · cited 4×
“For instance, a recent meta-analysis (Molendijk et al., 2014), although finding a significant increase of BDNF blood levels after antidepressant treatment, clearly identified evidence of publication bias and that larger samples and more recent papers reported smaller effects.”
InfluentialThe organization of the stress system and its dysregulation in depressive illness
Gold, P. W. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.163 · Cited by 654
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449 · cited 7×
“, 2017), which decrease after treatment (Kohler et al., 2018), and that anti-inflammatory agents may have antidepressant effects (Kohler et al.”
InfluentialSelf-citationPariante, C. M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.04.001 · Cited by 382 · cited 2×
“Although distinct, these theories are complementary since heightened stress response, observed in MDD, leads to increased activity of the hypothalamic-pituitary-adrenal axis and higher cortisol levels (Gold, 2015; Pariante, 2017) which could lead to an upregulation of pro-inflammatory cytokines accompanied by a downre…”
Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274 · cited 1×
“Here, we examined the role of several potential plasma biomarkers of MDD and/or antidepressant response (Brunoni et al., 2015; Brunoni et al., 2008; Chen et al., 2015; Hiles et al., 2012; Kohler et al., 2017a; Kohler et al., 2018; Kudinova et al., 2016; Lin and Tseng, 2015; Molendijk et al., 2014; Rivera-Rivera et al.…”
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175 · cited 1×
“, 2006) – this theory is supported by findings that acute increases in pro-inflammatory cytokines may lead to depressive episodes (Dellagioia and Hannestad, 2010), that higher levels of cytokines and chemokines are observed in depressed compared to healthy subjects (Kohler et al.”
Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142 · cited 1×
“, 2014) and; (2) “the neurotrophic factor hypothesis” that postulates that the depressive state is associated with decreased neuroplasticity, neuronal atrophy and aberrant neurogenesis in brain areas related to memory and mood (Duman et al., 1997; Sharma et al., 2016) - the theory is corroborated by findings that some…”
Self-citationLiu, C., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130204031 · Cited by 61 · cited 1×
“medium or high), and depression characteristics, such as treatmentresistant depression (binary), chronic depression (binary), and recurrent depression (binary) were used as covariates in all models as they might influence the outcome measures (Kohler et al., 2017; Kohler et al., 2018; Liu et al., 2014).”
Self-citationBrunoni, A. R., Machado-Vieira, R., Zarate, C. A., Vieira, E. L. M., Vanderhasselt, M.-A., Nitsche, M. A., Valiengo, L., Benseñor, I. M., Lotufo, P. A., Gattaz, W. F., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.006 · Cited by 60 · cited 3×
“Notwithstanding, our findings are in line with two previous randomized sham-controlled trials in depression that found that BDNF plasma levels did not predict tDCS antidepressant response and did not change after treatment (Brunoni et al., 2014b; Palm et al., 2013).”
Self-citation
Cited by
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429
Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression
Guo, B., Zhang, M., Hao, W., Wang, Y., Zhang, T., & Liu, C. (2023) · Translational Psychiatry · doi:10.1038/s41398-022-02297-y · Cited by 374
Zelada, M. I., Garrido, V., Liberona, A., Jones, N., Zúñiga, K., Silva, H., & Nieto, R. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914810 · Cited by 60
Lieb, K., Dreimüller, N., Wagner, S., Schlicht, K., Falter, T., Neyazi, A., Müller-Engling, L., Bleich, S., Tadić, A., & Frieling, H. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00511 · Cited by 54
“Fitting to this hypothesis is the observation that non-pharmacological approaches to the treatment of MDD such as transcranial direct current stimulation (tDCS) did not find associations between BDNF and treatment response (53).”
BackgroundSingh, A., Erwin-Grabner, T., Goya-Maldonado, R., & Antal, A. (2020) · Neuropsychobiology · doi:10.1159/000502149 · Cited by 23
Metadata
- Authors
- Brunoni, A. R., Padberg, F., Vieira, E. L. M., Teixeira, A. L., Carvalho, A. F., Lotufo, P. A., Gattaz, W. F., & Benseñor, I. M.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 86
- Pages
- 211-217
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2807701404
- Cited by
- 53
- References
- 19
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.